Submission RAL-THA-8f106089
|
|
0
|
111
|
August 26, 2021
|
Submission ALP-POS-e266d783
|
|
0
|
143
|
August 26, 2021
|
Submission ALP-POS-07e1ed01
|
|
0
|
123
|
August 26, 2021
|
Submission RAL-THA-952697e1
|
|
0
|
106
|
August 26, 2021
|
Submission ALP-POS-1460fd94
|
|
0
|
137
|
August 26, 2021
|
Submission ALP-POS-76eab5ce
|
|
0
|
139
|
August 25, 2021
|
Submission DAN-MCD-02570321
|
|
0
|
145
|
August 24, 2021
|
Submission PET-UNK-f360ae44
|
|
2
|
185
|
August 23, 2021
|
Submission WIL-UNI-2a57d06c
|
|
0
|
125
|
August 23, 2021
|
Submission MAT-POS-865c3497
|
|
0
|
122
|
August 22, 2021
|
Submission MIC-UNK-fbef42b7
|
|
0
|
129
|
August 22, 2021
|
Submission DAN-MCD-c163c0bb
|
|
0
|
144
|
August 21, 2021
|
Submission DAN-MCD-3ec20f87
|
|
0
|
182
|
August 21, 2021
|
Submission DAN-MCD-0742953f
|
|
0
|
136
|
August 21, 2021
|
Submission MIC-UNK-4fbd4db9
|
|
0
|
130
|
August 21, 2021
|
Submission MIC-UNK-9dc9fcd1
|
|
0
|
120
|
August 21, 2021
|
Submission MIC-UNK-7f86385f
|
|
0
|
114
|
August 21, 2021
|
Submission PET-UNK-37251634
|
|
0
|
109
|
August 21, 2021
|
Submission PET-UNK-c0891748
|
|
0
|
125
|
August 20, 2021
|
Submission DAN-MCD-0c04f563
|
|
0
|
153
|
August 20, 2021
|
Submission DAN-MCD-50d01569
|
|
0
|
116
|
August 20, 2021
|
Submission DAN-MCD-3bfdcef2
|
|
0
|
107
|
August 20, 2021
|
Submission MIC-UNK-f2576da4
|
|
0
|
124
|
August 19, 2021
|
Submission EDJ-MED-12c4873b
|
|
0
|
135
|
August 19, 2021
|
Submission EDJ-MED-239d8ca5
|
|
0
|
134
|
August 19, 2021
|
Submission AAR-UNI-c25c2f1e
|
|
0
|
135
|
August 19, 2021
|
Submission KEN-ILL-f8fa3277
|
|
0
|
152
|
August 17, 2021
|
Update on preclinical studies?
|
|
1
|
549
|
August 16, 2021
|
Submission BRU-THA-d60fe444
|
|
0
|
152
|
August 14, 2021
|
Submission EDJ-MED-378a25ea
|
|
0
|
147
|
August 13, 2021
|